Molecular BiologybioRxivPreprint
A PARP inhibitor, rucaparib, improves cardiac dysfunction in ADP-ribose-acceptor hydrolase 3 (Arh3) deficiency
Sachiko Yamashita, Xiangning Bu, Hiroko Ishiwata-Endo…·Joel Moss
This study shows that ARH3 deficiency causes cardiac dysfunction and that rucaparib, a PARP inhibitor, improves cardiac contractility and reduces infarct size in ARH3-deficient mice.
1 citation